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Introduction
Tuberculosis (TB) represents a multifactorial disease 
with an evolution and treatment response determined by 
the continuous interaction between Mycobacterial tuber-
culosis (MBT) and human genotype. Natural history and 
morphological features of the tuberculous infection are 
influenced by the degree of the multiplication and dis-
semination of MBT and host’s defense mechanisms [5]. The 
resistance against micobacterial infection is performed by 
macrophages through phagocitosis of MBT and by CD4 
lymphocytes through interleukin production. If at least 5 
MBT achieve the lung of a previously non-infected host 
there are two possibilities of outcome: 1) alveolar macro-
phages destroy MBT through their phagocytosis, 10% of 
cases; 2) surviving and intracellular division of the MBT [1]. 
The host response against mycobacterial infection consists 
of two phases: a 3rd type hypersensitivity reaction induced 
by the immune circulating complexes (antibody mediated) 
which is developing in 2-3 weeks after the infection and a 
4th type hypersensitivity (cell-mediated) developed in 8-12 
weeks. The 3rd type immune response is morphopathologi-
cally characterized by exudative lesions rich in active MBT 
and the 4th type represents nodular-proliferative granulo-
mas which contain the latent forms of MBT [1].
The nonspecific resistance of the organism against infec-
tion, including TB is based on the recognizing of the specific 
antigens as well as of the common antigenic groups called 
pathogen associated molecular patterns (PAMPs) [1]. The 
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Abstract
Background: Tuberculosis outcome and clinical features of the infection are influenced by the degree of the multiplication of mycobacterias, host’s defense 
mechanisms and the organism’s capacity to fight through the antioxidant mechanisms against the aggression of the oxidative stress. The aim of the study 
was to assess the oxidative stress and inflammatory biomarkers in pulmonary tuberculosis.
Material and methods: A prospective study, which included 46 patients with pulmonary tuberculosis and 36 healthy persons determined according to the 
clinical and biochemical criteria, was performed. The oxidative stress was assessed through the level of the advanced oxidation protein products, advanced 
glycation end-products, fibrinogen, amino acid catabolic products, activity of N-acetyl-β-D-glucosaminidase. The determination of the total antioxidant 
activity of plasma was performed through ABTS and CUPRAC methods. IL-8 and TNF-α were assessed using analysis kits of BOSTER (USA) producer.
Results: Was established high level of the oxidative stress following the assessment of the concentration of the advanced oxidation protein products, 
advanced glycation end-products, fibrinogen, N-acetyl-β-D-glucosaminidase, urea and creatinine. High concentration of amino acid catabolic products was 
attributed to the nephrotoxic properties of the medication. Was identified high level of the plasma total antioxidant activity and antioxidant compounds. 
Cytokines concentration IL-8 and TNF-α was several times higher than in the control group and they were assessed as specific biomarkers.
Conclusions: High level of the protein peroxidation, advanced glycation end-products, fibrinogen, protein catabolism compounds, pro-inflammatory 
cytokines – IL-8 and TNF-α confirmed the boosting of the oxidative stress. The elevated total antioxidant activity and antioxidant proteins demonstrated 
the organism’s capacity to redress the oxidative aggression.
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typical PAMPs are constituted from different substances 
such as: lipopolisaharides, endotoxins, peptidoglicans, viral 
nucleic acids, fungus β-glicans, flagelines, lipoteichoic acid, 
etc. The recognizing of the PAMPs is realised by the spe-
cific membrane receptors, defined as pattern-recognition 
receptors (PRR). The most important representatives of the 
PRR implicated in the TB immunity are: Toll-like receptors 
(TLRs), C-type lecithin receptors (CLRs) and Nod-like re-
ceptors (NLRs) [1]. The specified receptors are a family of 
the transmembranes proteins identified in many immune 
cells (macrophages, neutrophyles, dendritic cells, lympho-
cytes, mastocytes) and non-immune cells (enterocytes, as-
trocytes, hepatocytes, epithelial cells, etc.). Their stimula-
tion will activate the gene response by the production and 
releasing of the different types of the immune inductors: 
interleukins (IL), interferons (IFN), hematopoetic growth 
factors, tumor necrosis factors (TNF) and chemokines [1, 
5, 9,]. Interleukins regulate the systemic inflammatory re-
sponse before the development of the adaptive immunity. 
Pro-inflammatory cytokines are IL-1, IL-6, IL-8, IL-12 and 
are secreted as a specific response to specific molecules 
PAMPs that bind to pattern recognition receptors (PRRs), 
including Toll-like receptors (TLRs) [1]. IL-1 is a mitogenic 
protein, a lymphocyte B activating factor and a lymphocyte 
B differentiation factor [1]. IL-2 are secreted by the lectin 
stimulated T lymphocytes and B lymphocytes. It induces the 
differentiation of the T lymphocytes and activates B lym-
phocytes as a growth factor, being the antibody secretion 
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stimulant [1]. IL-6 is secreted by the T lymphocytes and 
macrophages during infection, inflammation, trauma as a 
specific response to PAMPs. It mediates the acute phase re-
sponse, the production of neutrophils and the maturation of 
B lymphocytes. IL-6 is the major regulator of the lympho-
cytes B transformation into plasmocytes [1]. IL-8 is released 
by phagocytes and mesenchymal cells induced by the IL-1 
and TNF-α. It activates neutrophil chemotaxis and their ac-
cumulation, lysosomal exocytosis and the OS at the site of 
the infection, inflammation, tissues ischemia or traumatism 
[4, 8, 9]. IL-12 is produced by the macrophages, neutrophils, 
dendritic cells, B-lymphoblastoid cells as a response to an-
tigenic stimulation. The main function represents the dif-
ferentiation of T lymphocytes into T helper 1 lymphocytes. 
It stimulates the production of IFN-γ and TNF-α from 
lymphocytes T and natural killer cells. TNF superfamily is 
a family of cytokines that cause the cell apoptosis [14]. The 
first described was TNF- α (also named cachectin) known 
as monocyte-derived cytotoxin involved in the cytolysis of 
certain cell lines, induces cachexia, fever (by IL-1 secretion) 
and cell differentiation [5]. The clinical expression of the cy-
tokines is various, but the most of them cause the endoge-
nous intoxication syndrome. Besides the immune response, 
the disease outcome depends on the organism’s capacity to 
fight through the antioxidant mechanisms against the ag-
gression of the oxidative stress (OS) determined by the re-
leased mycobacterial exotoxins and antituberculosis drugs 
[8]. OS is caused by the imbalance between the production 
of the free oxygen radicals and the capacity of the biological 
system to detoxify the peroxides and free radicals [12]. OS 
is manifested through the peroxidation of the cellular DNA, 
proteins, lipids, carbohydrates and other biological macro-
molecules. OS and protein peroxidation determine chronic 
metabolic disturbances with extensive fibrosis and collagen 
accumulation in the tissues, in consequence developing the 
multisystemic organ failure. The advanced oxidation pro-
tein products (AOPP) are important biomarkers of the OS. 
Those are constituted from uremic toxins which result from 
the interaction between the chlorine oxidants (chloramines 
and hypochlorus acid) with plasmatic proteins. The kid-
neys, spleen and the liver are major organs responsible for 
the isolation and excretion of the AOPP [16]. The increased 
blood concentration of AOPP is established in chronic in-
flammatory systemic diseases (systemic sclerosis), chronic 
kidney disease, hyperparathyroidism, atherosclerosis, dia-
betes mellitus, and during the treatment with calcium and 
vitamin D [16]. AOPP are structurally similar to advanced 
glycation end-products (AGEs) [15]. Elevated blood con-
centration of the AGEs can indicate the glucide metabolism 
disorders. The highest concentration of the AGEs is identi-
fied in diabetes mellitus patients and is determined by the 
non enzymatic glycosilation of the proteins and excessive 
activation of the polyol way during the hyperglycemia. The 
AGEs are heterogenous substances which result from the 
non-enzymatic glycation of the proteins, lipids and nucleic 
acid during a chain of reaction, defined Maillard reaction 
[11, 15]. Fibrinogen is an acute phase protein and rises in 
response to systemic inflammation, infections, trauma, can-
cer and thrombosis. Fibronogen is the biomarker of OS and 
inflammation, that demonstrates the functional effects on 
the fibrin clotting [1]. The antioxidant system is composed 
by the hydrophilic antioxidant compounds identified in the 
cytoplasm, blood serum and by the hydrophobic molecules 
localized in the biological membranes. Enzymatic antioxi-
dants from the blood and cellular cytoplasm are: superoxi-
de dismutase (SOD), catalase (CAT), glutathione reductase 
(GR), glutathione peroxidase (GPO) and gluthatione-S-
transferase (GST) [1]. 
The N-acetyl-beta-D-glucosaminidase (NAG) is a high 
molecular-weight hydrolytic lysosomal enzyme identified 
in different tissues (liver, kidneys, lungs, lymph, tears, urine, 
blood, etc.). It hydrolyses chemical chains of glycosides and 
amino carbohydrates that form structural components of 
the cell membrane and lysosomal membrane [17]. In the 
lungs this enzyme is secreted by alveolar macrophages in 
response to phagocytosis. Its role in the control of infec-
tion consists in the sterilizing activity within the intracel-
lular compartment of the macrophages [17]. Deficiency of 
the enzyme determines the susceptibility for reactivation 
of latent TB infection, dissemination and poor treatment 
outcome. High activity of NAG in the bronchoalveolar la-
vage indicates acute or chronic pulmonary injury, fibrosis, 
exposure to fibrogenic and nonfibrogenic dusts. The highest 
concentration of NAG is established in the proximal tubular 
cells of the kidneys. High activity in the urine provides in-
formation about the impairment of the tubular functions re-
sulting from a disease, nephrotoxicity of the anti-TB drugs 
and associated OS [17]. The anti-TB treatment is an impor-
tant risk factor for the metabolic disorders and elevation of 
OS [12]. The treatment for the drug susceptible TB consists 
in an association of the 1st line antituberculosis drugs (iso-
niazid, rifampicin, pyrazinamide, ethambutol and/or strep-
tomycin) during 6 months and for the drug-resistant TB an 
association of the 2nd line antituberculosis drugs for 18-24 
months. Adverse drug reactions are important clinical signs 
of the OS. The most frequent anti-TB drug reactions associ-
ated with the OS are the hepatotoxicity and nephrotoxic-
ity [12]. This study reflects a comparison of the OS indices, 
antioxidative activity and some inflammatory biomarkers 
in patients with pulmonary tuberculosis during the inten-
sive phase of the treatment compared with a representative 
sample of healthy persons. The aim of the study was the as-
sessment of the oxidative stress, antioxidative activity and 
inflammatory biomarkers in pulmonary TB.
Material and methods
It was realised a prospective study which included 46 
patients with pulmonary tuberculosis (study group) diag-
nosed in the municipal specialized institutions of Chisinau 
during the period 01.01.2016-31.08.2016 and 36 healthy 
persons determined according to the clinical and biochemi-
cal criteria (control group). Including criteria in the study 
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group were: age more than 18 years old, patient diagnosed 
with pulmonary TB, patient type “new case”, the diagnosis 
confirmed through the conventional microbiological meth-
ods, patients treated in the intensive phase in the frame of 
the Municipal Hospital of Phtisiopneumology in Chisinau 
and signed informed consent. The study schedule included 
information about the sex, age, clinical radiological diagno-
sis, case type, patient’s microbiological status and results of 
the drug susceptibility test, treatment regimen and adverse 
drug reactions. All patients included in the study were trea-
ted according to the national clinical protocol “Tuberculosis 
at adults”. The including criteria in the control group were: 
age more than 18 years old, healthy individual according to 
the clinical criteria and laboratory findings (complete blood 
count, biochemical tests; liver transaminases, blood electro-
lytes and signed informed consent. The assessment of the 
immune biochemical indices in the serum was performed 
using the methods with microquantities of the blood se-
rum and work reagents. The dosage was performed in mi-
cro plates with 96 wells, but the filling with the samples and 
reagents was performed with the automatic multichannel 
pipettes. The measure was performed using the chemical 
reagents and assessing the absorbance with the spectropho-
tometer in the maximum standardization of conditions. 
The total proteins were assessed according to the modified 
Lowry method [7]. The OS was assessed through the deter-
mination of the AOPP according to the modified method 
of Witko-Sarsat V. [7, 16] and AGEs according to the modi-
fied method of Sero L. [7, 13]. It included the spectropho-
tometric measure of the two main types of the AGEs: pen-
tosidine-like and vesperlysines-like. The micromethod was 
based on the fluorescence measure of the intensity of the 
studied samples diluted in the phosphate tampon at λexc 
335 nm, λem 385 nm (quuantification of the pentosidine-
like AGEs) and at λexc 370 nm, λem 440 nm (quantification 
of the vesperlysines-like AGEs) [7, 11]. The concentration 
of the urea and serum creatinine was assessed through the 
spectrophotometric analysis using the kits of the producer 
Eliteh (France) according to the attached instructions [6]. 
The concentration of fibrinogen was assessed using the kits 
of the producer Eliteh (France) according to the attached 
instructions [6].
The determination of the plasma total antioxidant activ-
ity was performed through two procedures: method based 
on the degradation of the 2,2-azino bis (3-ethylbenzotia-
zoline-6-sulphonic acid (ABTS) radical at the interaction 
with serum compounds with the antioxidant properties and 
measure of the decreasing absorbance at 734 nm [7] and 
CUPRAC method (Cupric Ion Reducing Antioxidant Capac-
ity) based on the reducing capacity of the Cu ion through 
the capture of the hydroxyl radical [2, 7]. The activity of 
N-acetyl-β-D-glucosaminidase was assessed according to 
the Gudumac V. method [6]. The concentration of the im-
mune cytokines of the IL-8 and TNF-α was assessed using 
the ELISA kits of the producer BOSTER (USA) according to 
the attached instructions.
The study methodology was based on the collection, 
statistical analysis, graphic representation and analytical 
assessment. Statistical analysis was realized by comparative 
assessment of the quantitative and qualitative features of the 
selected patients using the Microsoft Excel XP programme. 
Accumulated material was systematized in simple and com-
plex groups. For the assessment of differences between the 
indices of the compared samples it was performed the sta-
tistic non-parametric test “t test” and the significance thre-
shold “p” (p<0,05). 
Results
Distributing patients, according to the biological char-
acteristics, a similar rate of men and women was set in both 
groups, with the predomination of men in the same pro-
portion in both groups which ensured the comparability of 
the results. The same proportion of young persons aged less 
than 44 years was established in both groups, which was ac-
cepted as a condition permitting the comparability of the 
laboratory data (fig. 1).
Fig. 1.  Case distribution by sex and age.
Detected by passive way were 28 (56.52%) patients 
in the frame of the symptomatic case examination, 7 
(15.21%) through the examination of high risk groups and 
16 (34.78%) by direct addressing to the specialized health 
institution. The majority of patients, 43 (95.65%), were di-
agnosed with pulmonary infiltrative tuberculosis and 3 
(4.35%) with disseminated tuberculosis (fig. 2). At the ra-
diological examination was identified lung destruction in 
all patients of the study group. Microscopic examination of 
the smear for acid-fast-bacilli was positive in 30 (65.22%) 
cases. The conventional cultures revealed MBT colonies in 
26 (56.52%) cases. The drug susceptibility test established 
20 (43.47%) drug susceptible and 6 (13.04%) drug resistant 
strains of MBT. Monoresistance to isoniazid was established 
in 2 (4.34%) cases, but the polyresistance to isoniazid and 
streptomycin in 3 (6.52%) cases.
Standardized treatment for drug-sensitive TB was ad-
ministrated in 31 (67.39%) patients, standardized treat-
ment for MDR-TB (DOTS-Plus) in 13 (28.26%) patients 
and individualised regimen for polyresistant tuberculosis 
in 2 (4.34%) patients. Immune biochemical indices were 
analysed at 46 patients with pulmonary tuberculosis (study 
group) during the intensive phase of the treatment in the 
hospital performed according to the drug susceptibility test. 
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The collection (harvesting) of the blood of the control group 
was performed in ambulatory conditions. 
Fig. 2.  Clinical, radiological and microbiological characteristics 
of the tuberculosis patients.
Fibrinogen concentration, as a biomarker of the OS was 
more elevated in the group of the patients with tuberculosis 
compared to the control group. During the assessment of 
the most important products of the amino acid catabolism, 
was established that the concentration of urea in blood was 
significantly higher in the group of the patients with tuber-
culosis compared to the control group. In the same way were 
established the disturbances of the creatinine concentration, 
which was significantlty higher in the group of patients with 
tuberculosis (tab. 1).
Assessing obtained data it was established a statistical 
higher concentration of the AOPP in the group of patients 
with tuberculosis compared to the control group. The serum 
concentration of the AGEs pentosidine-like assessed through 
the fluorescence at 330 ex/390 em established a nonsignifi-
cant lower concentration in the group of patients with tu-
berculosis compared to the control group, but the concen-
tration of the AGEs vesperlysines-like at the fluorescence at 
370 ex/440 em demonstrated a significant higher level in 
the group of the patients with tuberculosis compared to the 
control group (fig. 3).
Assessing the results of the antioxidant activity of the 
serum through the method CUPRAC and ABTS it was es-
tablished a significant increasing of the antioxidant system 
compounds in the group of patients with tuberculosis com-
pared to the control group. The concentration of the cerulo-
plasmine, known as an acute phase protein with antioxidant 
role, was significantly higher in the group of patients with 
tuberculosis as well. The concentration of the total serum 
proteins (albumin and globulin α1, α2, β, γ) with antioxi-
dant role was established in a higher concentration in the 
group of patients with tuberculosis (fig 4).
Fig. 4  Comparative assessment of the antioxidant ativity and 
antioxidant compounds of the blood serum.
Table 1
Some indices of the oxidative stress
Oxidative system Parameter 
SG (N=46) CG (N=36)
P
M±SE M±SE
Oxidative stress biomarkers AOPP μMol/l 44,06±2,86 
(128%) 
34,349±3,58 (100%) 0,032
Pentosidine-like AGEs  μg/ml 174,3±15,41
 (84%)
208,5±16,27
(100%)
0,13
Vesperlysines-like 
AGEs, μg/ml
382,2±25,42
(111%)
343,2±49,63
(100%)
0,45
Fibrinogen mg/dl 40,90±1,02
(182%)
22,45±0,7
(100%)
<0,0001
Amino acid catabolism products Urea  mg/dL 18,92±9,2
(145%)
13,00±2,28
(100%)
0,02
Creatinine   mg/dL 79,79±6,84
(173%)
45,87±5,69
(100%)
0,0003
Note: AOPP – advanced oxidation protein products, AGEs – advanced glycation end-products (AGEs).
Fig. 3.  Oxidative stress biomarkers in the blood.
Note: AOPP – advanced oxidation protein products, AGEs – advanced 
glycation end-products (AGEs). 
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In terms of the quantitative data the total antioxidant 
activity determination was more elevated being assessed 
through the CUPRAC method compared with ABTS. Ceru-
loplasmine, an acute phase reactant with copper-dependent 
anti-oxidant activity, was more elevated than the serum to-
tal proteins, which include albumin and globulins (α1, α2, β 
and γ globulins). Data are shown in the table 2.
Assessed inflammatory biomarkers constituted the ac-
tivity of the N-acetyl-β-D-glucosaminidase (NAG), the 
concentration of IL-8 and TNF-α. The NAG activity was 
higher in the group of patients with tuberculosis in com-
parison with the control group. The concentration of the 
pro-inflammatory cytokine IL-8 was 10 times higher in 
the serum of the patients with tuberculosis in comparison 
with the control group. The concentration of the TNF-α was 
three times higher than in the control group (tab. 3).
Table 3
Pro-inflammatory biomarkers
Parameters
SG (N=46) CG (N=36)
P
M±SE M±SE
NAG
80,48±5,315
(122%)
65,88±3,06
(100%)
0,027
IL-8
ng/ml
15,595±8,411
(1134,05%)
1,163±1,685
(100%)
<0,0001
TNF-α
pg/ml
212,41±195,5
(323%)
65,78±12,09
(100%)
<0,0001
NG N-acetyl-β-D-glucosaminidase.
Discussion
Distribution of patients in sex and age groups deter-
mined the predomination of the men and economic re-
productive age in both selected samples, which allowed the 
comparability of the results. Diagnosed through at least one 
microbiological conventional method the patients with a 
wrong diagnosis were excluded. The diagnosis of the pul-
monary infiltrative tuberculosis and lung destruction in a 
high propotion demonstrated the similarity of the selected 
group with the national cohorts [10].
Estimation of the level of the oxidative stress markers 
through the serum concentration of the advanced oxidation 
protein products, fibrinogen and products of the protein ca-
tabolism demonstrated the presence of a higher peroxida-
tive stress in the group of patients with tuberculosis. Studies 
evaluating advanced oxidation protein products and ad-
vanced glycation end-products in patients with tuberculosis 
in the specialised literature have not been identified. High 
values of urea and creatinine are comparable to the results 
of international studies, being attributed to the nephrotoxic 
properties of medications of the aminoglycoside group in-
cluded in the regimen of every patient, but also can be ex-
plained by the exacerbation of the catabolism [8].
The concentration of the pentosidine-like advanced gly-
cation end-products at a lower level in patients with tuber-
culosis, demonstrated the metabolic changes during star-
vation. The concentration of the vesperlysine-like advanced 
glycation end-products was insignificantly higher in the 
group of tuberculosis patients. The level was lower than in 
comorbid diabetic patients associated with tuberculosis re-
ported in international studies [11].
The markers of the serum antioxidant system underwent 
elevated changes in the group of the tuberculosis patients. 
The similar results from the specialised literature dem-
onstrated the hyperactivity of the defensive mechanisms 
against mycobacterial exotoxins as well as the increased 
metabolic detoxification of the antituberculosis medication 
[8]. The intensification of the blood antioxidant activity in 
patients with pulmonary tuberculosis was demonstrated 
also by the high concentration of the ceruloplasmine and 
total serum proteins. The same results were identified in 
other scientific papers [3].
The elevated activity of NAG in the blood of patients 
with pulmonary tuberculosis indicated pulmonary injury 
due to infectious aggresion of MBT. No similar studies were 
reported in the specialized literature. The quantitative im-
munoassay revealed that IL-8 was significantly elevated in 
the patients with tuberculosis. Considering the fact that 
IL-8 is a chamotactic factor for neutrophils, lymphocytes T 
and basophils its pivotal role in the  modulation of acute 
and chronic inflammation can be deducted by obtained re-
sults also [4, 9]. Assessment of TNF-α established it as one 
of the most important mediator of the inflammation in the 
antimycobacterial cytokine cascade that suggests acute pul-
monary inflammation and apoptosis in pulmonary tuber-
culosis [14].
Table 2
Some indices of the antioxidative activity
Antioxidant defense Parameter 
SG (N=46) CG (N=36)
P
M±SE M±SE
Total antioxidant activity 
(tAOA)
Method ABTS mMol/l 0,77±0,005
(110%)
0,71±0,004 (100%) <0,0001
Method CUPRAC mMol/l 1,09±0,18 (210%) 0,517±0,04 (100%) 0,008
Proteins with antioxidant role Ceruloplasmine  mg/l 887,2±36,48 (123%) 724,3±27,8 (100%) 0,0008
Serum total protein g/l 59,4±3,61
(114%)
57,1±2,3
(100%)
0,001
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Conclusions
In conclusion, in tuberculosis the increased level of the 
protein peroxidation, advanced glycation end products, fi-
brinogen, protein catabolism compounds and pro-inflam-
matory cytokines: IL-8 and TNF-α confirmed the boosting 
of the oxidative stress. The increased total antioxidant ac-
tivity, elevated concentration of the proteins with the anti-
oxidant role in pulmonary tuberculosis demonstrated the 
organism’s capacity to redress the oxidative aggression.
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